Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devin B Lowe

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|October 18, 2023
Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progressionAmanda L McCormick, Trevor S Anderson, Elizabeth A Daugherity, et al.
NPJ Vaccines|June 23, 2026
Therapeutic DC vaccination against the vascular antigen DLK1 effectively treats primary triple-negative breast cancer and prevents metastasisElizabeth A Daugherity, Caryn Lawrence, Izuchukwu F Okpalanwaka, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2012
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigenJoel F Aldrich, Michael H Shearer, Devin B Lowe, et al.
Journal of Virology|May 20, 2011
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNAJoel F Aldrich, Devin B Lowe, Michael H Shearer, et al.
Virology|January 22, 2005
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunizationDevin B Lowe, Michael H Shearer, James A Tarbox, et al.
Molecular Cancer Therapeutics|April 9, 2025
A PD-L1/CD3 BISPECIFIC ANTIBODY ENHANCES THE ANTI-TUMOR EFFECTS OF REGORAFENIB AGAINST COLON CANCERIzuchukwu F Okpalanwaka, Elizabeth A Daugherity, Amanda L McCormick, et al.
Journal of Visualized Experiments : Jove|April 14, 2015
Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technologyJon A Weidanz, Krysten L Doll, Soumya Mohana-Sundaram, et al.
Oncoimmunology|October 2, 2023
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protectionTrevor S Anderson, Amanda L McCormick, Elizabeth A Daugherity, et al.
Mabs|March 9, 2017
TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targetsDevin B Lowe, Camille K Bivens, Alexis S Mobley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2012
Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic miceXi Zhao, Anamika Bose, Hideo Komita, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|October 18, 2023
Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progressionAmanda L McCormick, Trevor S Anderson, Elizabeth A Daugherity, et al.
NPJ Vaccines|June 23, 2026
Therapeutic DC vaccination against the vascular antigen DLK1 effectively treats primary triple-negative breast cancer and prevents metastasisElizabeth A Daugherity, Caryn Lawrence, Izuchukwu F Okpalanwaka, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2012
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigenJoel F Aldrich, Michael H Shearer, Devin B Lowe, et al.
Journal of Virology|May 20, 2011
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNAJoel F Aldrich, Devin B Lowe, Michael H Shearer, et al.
Virology|January 22, 2005
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunizationDevin B Lowe, Michael H Shearer, James A Tarbox, et al.
Molecular Cancer Therapeutics|April 9, 2025
A PD-L1/CD3 BISPECIFIC ANTIBODY ENHANCES THE ANTI-TUMOR EFFECTS OF REGORAFENIB AGAINST COLON CANCERIzuchukwu F Okpalanwaka, Elizabeth A Daugherity, Amanda L McCormick, et al.
Journal of Visualized Experiments : Jove|April 14, 2015
Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technologyJon A Weidanz, Krysten L Doll, Soumya Mohana-Sundaram, et al.
Oncoimmunology|October 2, 2023
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protectionTrevor S Anderson, Amanda L McCormick, Elizabeth A Daugherity, et al.
Mabs|March 9, 2017
TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targetsDevin B Lowe, Camille K Bivens, Alexis S Mobley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2012
Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic miceXi Zhao, Anamika Bose, Hideo Komita, et al.
Pageof 4